…5%) lost to follow up. 3 (1.4%) patients in Group 1 developed a hepatocellular carcinoma (HCC). Of the 46 patients in Group 2, 21 (46%) had a repeat LSM…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 250 of 2459…10 mg monotherapy (n=50), (B) BLV 10 mg for 96W (n=100), or (C) BLV 10 mg for 144W (n=50). Patient follow-up (FU) continued for 48W…
…rst alarmed by their diagnosis. 76/89 (85%) believed testing of BBV and receiving a diagnosis through opt-out testing was beneficia…
…patient with IBD-U/PSC. IBD/AIH/AISC subtypes were treated with prednisolone (61.5%), azathioprine (76.9%) or mycophenolate mofetil (15.4%).…
…n shown to be protective against development and progression of hepatocellular carcinoma (HCC). We investigated in human in vitro models of pre-cancerou…
…Background Liver cancer is the sixth most common cancer worldwide. Hepatocellular carci…
… of fracture patients received vitamin D therapy; none received bisphosphonates. Patients with recent falls were significantly more likely to h…
…ic review identified studies in the UK and Ireland reporting on myopia prevalence (n=15), progression (n=4), pathological changes (n=1…
…ted with systemic immunosuppression, including a combination of methotrexate (n=6), adalimumab (n=5), mycophenolate (n=2), oral corticostero…
…Posterior fossa tumours comprise up to 70% of paediatric brain tumours. To date, no UK …
…ze treatment selection for patients with early-stage inoperable NSCLC. If validated, it could serve as a foundation for a treatment-f…
…ntributes to postpartum glucose intolerance in EGDM.Conclusions EGDM in women without obesity is associated with a high risk for pos…